Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: melanoma


It’s way too soon to know if melanoma blood test will save ‘thousands of lives’


HealthDay cautiously reports results of Opdivo melanoma study


It’s misleading to call results from phase 1 trials with 6 and 13 patients a ‘cancer breakthrough’


‘Game-changer, Holy Grail, groundbreaking’ used in Philly Inquirer story on phase 1 trial


Reuters Health briefly but aptly reports survey findings of partner-assisted skin exams for melanoma survivors


Except for presidential anecdote, NBC story on new melanoma drug was well-balanced


Coverage of virus-based cancer treatment skimps on cautions and key outcomes


Keytruda and colon cancer: coverage of benefits not balanced with harms and cost info


Survival statistic unbalances coverage of virus-based melanoma therapy

1 5/18/2015

Rosy CBS report on vitamin study lacks meaningful description of skin cancer impact